ENDRA Life Sciences
NDRA
11 hedge funds and large institutions have $1.97M invested in ENDRA Life Sciences in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
187% more capital invested
Capital invested by funds: $686K → $1.97M (+$1.29M)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
22% more funds holding
Funds holding: 9 → 11 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$240K |
| 2 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
+$134K |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$80.1K |
| 4 |
Renaissance Technologies
New York
|
+$53.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$33K |
| 2 |
VF
Virtu Financial
New York
|
-$31K |
| 3 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
-$15K |
NDRA Hedge Fund Activity: Q4 2020 in Review
11 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2020, worth a combined $1.97M — up 187% from $686K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NDRA positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Worth Venture Partners, opening a new position worth an estimated $240K. The largest seller was Citadel Advisors, exiting entirely with an estimated $33K sold.
- 11 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2020, up from 9 in Q3 2020.
- Funds reported $1.97M of ENDRA Life Sciences stock for Q4 2020, up 187% quarter-over-quarter.
- 6 funds opened new ENDRA Life Sciences positions in Q4 2020 and 3 closed out, a net change of +3 holders.
- The largest ENDRA Life Sciences buyer in Q4 2020 was Worth Venture Partners, an estimated $240K added.
- The largest ENDRA Life Sciences seller in Q4 2020 was Citadel Advisors, an estimated $33K sold.
Based on aggregated 13F filings for Q4 2020.